| Identification | Back Directory | [Name]
Urea, N-[1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]- | [CAS]
168161-71-5 | [Synonyms]
CCK-B Receptor Antagonist 1
Urea, N-[1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]- | [Molecular Formula]
C28H30N6O3 | [MDL Number]
MFCD31544444 | [MOL File]
168161-71-5.mol | [Molecular Weight]
498.58 |
| Chemical Properties | Back Directory | [Boiling point ]
723.0±60.0 °C(Predicted) | [density ]
1.25±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 125 mg/mL (250.71 mM) | [form ]
Solid | [pka]
11.38±0.40(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor, and has the potential of reducing the secretion of gastric acid. | [storage]
Store at -20°C | [References]
[1] Hamish Ryder, et al. Benzodiazepin derivatives useful as cck-receptor antagonists. WO 1993016999 A1. |
|
|